Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Finished Drug Prices
NA
1. Lokelma
2. Sodium Zirconium Cyclosilicate
3. Zs-9 Compound
1. Uzsi 9
2. Zs-9 Compound
3. Uzsi-9
4. Unii-d652zwf066
5. Zs 9
Molecular Weight | 371.50 g/mol |
---|---|
Molecular Formula | H6Na2O9Si3Zr+2 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 0 |
Exact Mass | 369.816199 g/mol |
Monoisotopic Mass | 369.816199 g/mol |
Topological Polar Surface Area | 149 Ų |
Heavy Atom Count | 15 |
Formal Charge | 2 |
Complexity | 131 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 4 |
Ion Exchange Resins
High molecular weight, insoluble polymers which contain functional groups that are capable of undergoing exchange reactions (ION EXCHANGE) with either cations or anions. (See all compounds classified as Ion Exchange Resins.)
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-02-16
Pay. Date : 2022-01-13
DMF Number : 36363
Submission : 2021-12-07
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-04-18
Pay. Date : 2022-03-23
DMF Number : 36413
Submission : 2022-03-16
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-01-28
Pay. Date : 2021-11-18
DMF Number : 36438
Submission : 2021-12-10
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-04-19
Pay. Date : 2022-03-17
DMF Number : 36915
Submission : 2022-03-17
Status : Active
Type : II
NDC Package Code : 65977-0132
Start Marketing Date : 2018-05-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38236
Submission : 2023-03-31
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-04-19
Pay. Date : 2022-03-17
DMF Number : 36915
Submission : 2022-03-17
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-01-28
Pay. Date : 2021-11-18
DMF Number : 36438
Submission : 2021-12-10
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-04-18
Pay. Date : 2022-03-23
DMF Number : 36413
Submission : 2022-03-16
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-02-16
Pay. Date : 2022-01-13
DMF Number : 36363
Submission : 2021-12-07
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38236
Submission : 2023-03-31
Status : Active
Type : II
SODIUM ZIRCONIUM CYCLOSILICATE
NDC Package Code : 0310-2111
Start Marketing Date : 2021-12-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER, FOR SUSPENSION (243kg/243kg)
Marketing Category : BULK INGREDIENT
SODIUM ZIRCONIUM CYCLOSILICATE
NDC Package Code : 65977-0132
Start Marketing Date : 2018-05-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Sodium Zirconium Cyclosilicate
About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product ...
Regulatory Info : RX
Registration Country : USA
SODIUM ZIRCONIUM CYCLOSILICATE
Brand Name : LOKELMA
Dosage Form : FOR SUSPENSION;ORAL
Dosage Strength : 5GM/PACKET
Packaging :
Approval Date : 2018-05-18
Application Number : 207078
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
SODIUM ZIRCONIUM CYCLOSILICATE
Brand Name : LOKELMA
Dosage Form : FOR SUSPENSION;ORAL
Dosage Strength : 10GM/PACKET
Packaging :
Approval Date : 2018-05-18
Application Number : 207078
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Prescription
Registration Country : Canada
SODIUM ZIRCONIUM CYCLOSILICATE
Brand Name : LOKELMA
Dosage Form : POWDER FOR SUSPENSION
Dosage Strength : 5G/SACHET
Packaging :
Approval Date :
Application Number : 2490714
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
SODIUM ZIRCONIUM CYCLOSILICATE
Brand Name : LOKELMA
Dosage Form : POWDER FOR SUSPENSION
Dosage Strength : 10G/SACHET
Packaging :
Approval Date :
Application Number : 2490722
Regulatory Info : Prescription
Registration Country : Canada
RLD : Yes
TE Code :
SODIUM ZIRCONIUM CYCLOSILICATE
Brand Name : LOKELMA
Dosage Form : FOR SUSPENSION;ORAL
Dosage Strength : 5GM/PACKET
Approval Date : 2018-05-18
Application Number : 207078
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
SODIUM ZIRCONIUM CYCLOSILICATE
Brand Name : LOKELMA
Dosage Form : FOR SUSPENSION;ORAL
Dosage Strength : 10GM/PACKET
Approval Date : 2018-05-18
Application Number : 207078
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
Regulatory Info : Prescription
Registration Country : Canada
SODIUM ZIRCONIUM CYCLOSILICATE
Brand Name : LOKELMA
Dosage Form : POWDER FOR SUSPENSION
Dosage Strength : 5G/SACHET
Packaging :
Approval Date :
Application Number : 2490714
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
SODIUM ZIRCONIUM CYCLOSILICATE
Brand Name : LOKELMA
Dosage Form : POWDER FOR SUSPENSION
Dosage Strength : 10G/SACHET
Packaging :
Approval Date :
Application Number : 2490722
Regulatory Info : Prescription
Registration Country : Canada
Global Sales Information
Market Place
Reply
09 Aug 2024
Reply
21 Jun 2021
Reply
18 May 2020
Reply
10 May 2019
Patents & EXCLUSIVITIES
Patent Expiration Date : 2035-10-14
SODIUM ZIRCONIUM CYCLOSILICATE
US Patent Number : 11738044
Drug Substance Claim :
Drug Product Claim :
Application Number : 207078
Patent Use Code : U-2312
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-10-14
Patent Expiration Date : 2035-10-14
SODIUM ZIRCONIUM CYCLOSILICATE
US Patent Number : 9592253
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 207078
Patent Use Code : U-2312
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-10-14
Patent Expiration Date : 2033-10-22
SODIUM ZIRCONIUM CYCLOSILICATE
US Patent Number : 8877255
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 207078
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-10-22
Patent Expiration Date : 2035-10-14
SODIUM ZIRCONIUM CYCLOSILICATE
US Patent Number : 11738044
Drug Substance Claim :
Drug Product Claim :
Application Number : 207078
Patent Use Code : U-2312
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-10-14
Patent Expiration Date : 2033-10-22
SODIUM ZIRCONIUM CYCLOSILICATE
US Patent Number : 9913860
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 207078
Patent Use Code : U-2312
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-10-22
Patent Expiration Date : 2032-02-10
SODIUM ZIRCONIUM CYCLOSILICATE
US Patent Number : 11406662
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 207078
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-02-10
Patent Expiration Date : 2032-02-10
SODIUM ZIRCONIUM CYCLOSILICATE
US Patent Number : 9861658
Drug Substance Claim :
Drug Product Claim :
Application Number : 207078
Patent Use Code : U-2312
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-02-10
Patent Expiration Date : 2035-10-14
SODIUM ZIRCONIUM CYCLOSILICATE
US Patent Number : 10300087
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 207078
Patent Use Code : U-2312
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-10-14
Patent Expiration Date : 2032-04-19
SODIUM ZIRCONIUM CYCLOSILICATE
US Patent Number : 8802152
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 207078
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-04-19
Patent Expiration Date : 2033-10-22
SODIUM ZIRCONIUM CYCLOSILICATE
US Patent Number : 9913860
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 207078
Patent Use Code : U-2312
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-10-22
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?